Journal Title:Current Gene Therapy
Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.
Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.
Current Gene Therapy 是一本同行评审的双月刊,面向对疾病基因和细胞治疗的基础研究和临床应用等主要主题感兴趣的学术和工业科学家。细胞疗法手稿还可以包括对细胞进行基因改造后在疾病中的应用。 Current Gene Therapy 发表关于基因转移和基因表达分析、载体开发、细胞基因工程、动物模型和人类临床应用基因和细胞疗法治疗疾病的最新进展的完整/迷你评论和原创研究。< /p>
Current Gene Therapy 发表评论和原创研究,其中包含有关基因和细胞疗法的实验数据。该杂志还包括关于基因和细胞治疗的技术进步、伦理和监管考虑的手稿。评论应该为读者提供对应用于分子医学的任何实验生物学领域的全面评估,这不仅在基因治疗和细胞治疗的特定领域具有重要意义,而且对其他领域的研究人员也很感兴趣。鼓励作者为未来的进步提供自己的评估和愿景。还欢迎对尚未积累大量文献的最新发现进行评论。这些评论为最近基因治疗实验研究的重点主题提供了一个论坛,主要是为了使临床和基础研究人员都能获得这些结果。包含实验数据的手稿应该是原始数据,之前没有发表过。
Current Gene Therapy创刊于2001年,由BENTHAM SCIENCE PUBL LTD出版商出版,收稿方向涵盖医学 - 遗传学全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度约稿?周期不定,影响因子指数2.431,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | GENETICS & HEREDITY 遗传学 | 4区 | 是 | 是 |
名词解释:
中科院分区也叫中科院JCR分区,基础版分为13个大类学科,然后按照各类期刊影响因子分别将每个类别分为四个区,影响因子5%为1区,6%-20%为2区,21%-50%为3区,其余为4区。
WOS分区等级 | JCR所属学科 | 分区 |
Q2 | GENETICS & HEREDITY | Q2 |
名词解释:
WOS即Web of Science,是全球获取学术信息的重要数据库,Web of Science包括自然科学、社会科学、艺术与人文领域的信息,来自全世界近9,000种最负盛名的高影响力研究期刊及12,000多种学术会议多学科内容。给期刊分区时会按照某一个学科领域划分,根据这一学科所有按照影响因子数值降序排名,然后平均分成4等份,期刊影响因子值高的就会在高分区中,最后的划分结果分别是Q1,Q2,Q3,Q4,Q1代表质量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||||||||||||||
6.90 | 0.564 | 0.640 |
|
名词解释:
CiteScore:衡量期刊所发表文献的平均受引用次数。
SJR:SCImago 期刊等级衡量经过加权后的期刊受引用次数。引用次数的加权值由施引期刊的学科领域和声望 (SJR) 决定。
SNIP:每篇文章中来源出版物的标准化影响将实际受引用情况对照期刊所属学科领域中预期的受引用情况进行衡量。
是否OA开放访问: | h-index: | 年文章数: |
未开放 | 65 | 40 |
Gold OA文章占比: | 2021-2022最新影响因子(数据来源于搜索引擎): | 开源占比(OA被引用占比): |
3.60% | 3.6 | 0 |
研究类文章占比:文章 ÷(文章 + 综述) | 期刊收录: | 中科院《国际期刊预警名单(试行)》名单: |
55.56% | SCI、SCIE | 否 |
历年IF值(影响因子):
历年引文指标和发文量:
历年中科院JCR大类分区数据:
历年自引数据:
2019-2021国家/地区发文量统计:
国家/地区 | 数量 |
CHINA MAINLAND | 58 |
USA | 17 |
India | 13 |
Iran | 8 |
Saudi Arabia | 7 |
Italy | 6 |
Japan | 5 |
Bangladesh | 4 |
Argentina | 3 |
Australia | 2 |
2019-2021机构发文量统计:
机构 | 数量 |
SICHUAN UNIVERSITY | 11 |
COLLABORAT INNOVAT CTR BIOTHERAP... | 6 |
STATE UNIVERSITY SYSTEM OF FLORI... | 6 |
CENTRAL SOUTH UNIVERSITY | 5 |
FUDAN UNIVERSITY | 5 |
HARBIN INSTITUTE OF TECHNOLOGY | 5 |
HARBIN MEDICAL UNIVERSITY | 5 |
HUAZHONG UNIVERSITY OF SCIENCE &... | 4 |
JAMIA HAMDARD UNIVERSITY | 4 |
CAPITAL MEDICAL UNIVERSITY | 3 |
近年引用统计:
期刊名称 | 数量 |
NATURE | 59 |
P NATL ACAD SCI USA | 58 |
J IMMUNOL | 48 |
NUCLEIC ACIDS RES | 46 |
CELL | 42 |
PLOS ONE | 38 |
MOL THER | 37 |
CURR GENE THER | 35 |
SCIENCE | 35 |
NAT COMMUN | 29 |
近年被引用统计:
期刊名称 | 数量 |
CURR GENE THER | 35 |
INT J MOL SCI | 30 |
MOL THER-METH CLIN D | 26 |
SCI REP-UK | 25 |
HUM GENE THER | 23 |
J CELL PHYSIOL | 14 |
VIRUSES-BASEL | 14 |
GENES-BASEL | 13 |
FRONT IMMUNOL | 11 |
MOL THER | 11 |
近年文章引用统计:
文章名称 | 数量 |
Current RNA-based Therapeutics i... | 14 |
Nonviral Delivery Systems for Ca... | 13 |
Dysfunction in Brain-Derived Neu... | 13 |
Genetics and Therapies for GM2 G... | 13 |
The Therapeutic Potential and Ro... | 12 |
EZH2 RIP-seq Identifies Tissue-s... | 10 |
Functional Improvement of Chimer... | 9 |
A Brief Survey of Machine Learni... | 9 |
miR-7 Replacement Therapy in Par... | 9 |
A Mendelian Randomization Study ... | 7 |
同类学科的其他优质期刊 | 影响因子 | 中科院分区 |
Journal Of Clinical Immunology | 6.780 | 2区 |
Journal Of Infection In Developing Countries | 0.703 | 4区 |
Acta Medica Okayama | 0.642 | 4区 |
Child And Adolescent Psychiatry And Mental Health | 2.061 | 3区 |
Bratislava Medical Journal-bratislavske Lekarske Listy | 1.200 | 4区 |
American Journal Of Hematology | 6.973 | 1区 |
Npj Vaccines | 5.699 | 1区 |
Vox Sanguinis | 2.347 | 4区 |
Contact Dermatitis | 3.952 | 2区 |
Cancer Nursing | 1.850 | 2区 |
本站主要从事期刊咨询服务,不是任何杂志官网,不涉及任何出版事务、本站仅提供有限咨询服务,需要用户自己向出版商投搞且没有绿色通道,是否录用一切以出版商通知为准,本站提供的期刊信息均来源于国家新闻出版总署及网络,仅供参考,提及的第三方名称或商标,其知识产权均属于相应的出版商或期刊,本站与上述机构无从属关系,所有引用均出于解释服务内容的考量,符合商标法规范,本页信息均由法务团队进行把关,若期刊信息有任何问题,请联系我们,我们会认真核实处理。若用户需要出版服务,请联系出版商!
发表直通车,欢迎来到发表直通车
鲁ICP备2024070538号-2
鲁公网安备37152102000140